AddressPosted Date: Mar 18 2024
Digital, Data, Analytics and Performance (DDAP) team in pipeline Project Management group is now seeking an experienced Performance Management Partner to lead the pipeline reporting engagement with the Development Leadership Team (DLT) and Pipeline Project Management leadership team (PPM LT).
This role will use a set of analytics tools and processes.
We create a place where people can grow, be their best, be safe, and feel welcome, valued and included. We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension plan membership, and shares and savings programme.
We embrace modern work practises; our Performance with Choice programme offers a hybrid working model, empowering you to find the optimal balance between remote and in-office work.
Discover more about our company wide benefits and life at GSK on our webpage Life at GSK | GSK
In this role you will
- Partner with the leadership team to discover and define the analytics opportunities to drive business value for better decision making and planning. Define performance metrics of PPM, generate Insights on performance metrics of PPM against targets - performance benchmarking.
- Identify opportunities for optimal delivery of R&D pipeline through data and insights. Leverage modern data visualization and analytics technologies. Act as go to person for the knowledge and foresight of pipeline reporting in R&D
- Own monthly delivery of pipeline performance reporting and insights to DLT /PPM LT. (Pipeline status reporting, Internal and external Key events).
- Lead Data Collation & collaboration for key inputs from Project management community, Resource Management and Finance for monthly cadence - insights communication. Activity will involve investigation and resolution of data gaps and inconsistencies in the reporting.
- Represent the PPM - DDAP analytics group in discussions with senior stakeholders regarding the structure and technical components of the analytics that we are deploying.
- Demonstrate strategic approach with an understanding of the underlying story behind the data, answering “so what” and able to translate that with ease to the PPM LT/DLT
Why you?
Basic Qualifications & Skills:
We are looking for professionals with these required skills to achieve our goals:
- Bachelor’s degree in computer science, Economics, Finance, Life Science, Software Engineering, Maths, Bioinformatics or related discipline
- Extensive experience in Pharma R&D reporting
- Experience generating modelling requirements from ad hoc and ambiguous questions.
- Familiar with metadata management and data governance concepts
- Strong analytical and problem-solving skills, with the ability to make data-driven development decisions.
- Excellent communication, collaboration, and stakeholder management skills.
Preferred Qualifications & Skills:
Please note the following skills are not necessary, just preferred, if you do not have them, please still apply:
- Working technical knowledge of key decision science / risk modelling methodologies
- Experience in PowerBI, Spotfire or other visualisation tools
- Strong leadership abilities and a self-driven, proactive approach. Ability to thrive in a fast-paced, dynamic environment and manage multiple priorities effectively.
Closing Date for Applications – 4th April 2024 (COB)
Please take a copy of the Job Description, as this will not be available post closure of the advert.
When applying for this role, please use the ‘cover letter’ of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application.
Why Us?
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organization where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030.
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We’re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.
As an Equal Opportunity Employer, we are open to all talent. In the US, we also adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to neurodiversity, race/ethnicity, colour, national origin, religion, gender, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class*(*US only).
We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.
Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on Ukdiversity.recruitment@gsk.com or 0808 234 4391.
Please note should your enquiry not relate to adjustments, we will not be able to support you through these channels. However, we have created a UK Recruitment FAQ guide. Click the link and scroll to the Careers Section where you will find answers to multiple questions we receive
As you apply, we will ask you to share some personal information which is entirely voluntary. We want to have an opportunity to consider a diverse pool of qualified candidates and this information will assist us in meeting that objective and in understanding how well we are doing against our inclusion and diversity ambitions. We would really appreciate it if you could take a few moments to complete it. Rest assured, Hiring Managers do not have access to this information and we will treat your information confidentially.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit GSK’s Transparency Reporting For the Record site.
We’re moving towards a more sustainable future with our new headquarters. With better public transport links and proximity to world-class science and technology institutions, we’re excited for our move to the vicinity of Earnshaw Street, London WC1A (“the New HQ”) by end H1 2024.
